Blogs Contact Us Login
Media stay informed Investor relations News and press archive Media archive Resources Overview

Contact us:
Media Relation Investor & External Relations Mondobiotech holding AG
Das Kloster
Mürgstrasse 18
CH-6370 Stans - Switzerland

T +41 (0)840 200 010
F +41 (0)840 200 011

media@mondobiotech.com
July 2012
July 17, 2012 mondoBIOTECH Holding AG’s (SIX:RARE) announces today to have entered into a 3-year investment agreement with GEM Group
Stans, Switzerland

mondoBIOTECH holding AG (SIX: RARE) announces that it has signed an investment agreement with the alternative investment firm, The Global Emerging Markets Group (GEM), whose funds will invest up to CHF 11 million into the Company over the next three years.

download file: En  | 
July 11, 2012 mondoBIOTECH's medicinal product candidate DasKloster 0039 granted patent for treatment of Hepatitis B virus infection by the US Patent Office
Stans, Switzerland

mondoBIOTECH holding AG (SIX: RARE) announces today to have been granted the patent for the method of treatment of Hepatitis B virus infection by the United States Patent Office, for its medicinal product candidate DasKloster 0039.

download file: En  |